AI-driven collateral analysis helps lenders identify appraisal issues early, reducing defects and repurchase risk - ...
Oral presentation of biomarker data shows RP1 plus nivolumab reverses multiple resistance mechanisms to PD-1 blockade in advanced melanoma following definitive anti-PD-1 failureWOBURN, Mass., Nov. 07, ...